A multi-institution analysis of outcomes of liver-directed surgery for metastatic renal cell cancer

HPB

Volumn 14, Issue 8, 2012, Pages 532-538

  Hatzaras, Ioannis ^a   Gleisner, Ana L ^a   Pulitano, Carlo ^b   Sandroussi, Charbel ^c   Hirose, Kenzo ^a   Hyder, Omar ^a   Wolfgang, Christopher L ^a   Aldrighetti, Luca ^b   Crawford, Michael ^c   Choti, Michael A ^a   Pawlik, Timothy M ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Hepatectomy; Liver metastasis; Metastasectomy; Outcomes; Renal cell carcinoma; Surgery

Indexed keywords

ADULT; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; LIVER METASTASIS; LIVER RESECTION; LYMPH NODE METASTASIS; MALE; MORTALITY; OVERALL SURVIVAL; PATIENT SAFETY; POSTOPERATIVE HEMORRHAGE; RESPIRATORY FAILURE; THERAPY EFFECT; TREATMENT OUTCOME; TUMOR VOLUME; WOUND INFECTION;

EID: 84863722901     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2012.00495.x     Document Type: Article

References (17)

1. Motzer RJ, Agarwal N, Beard C, Bolger GB, Boston B, Carducci MA, et al,. (2012) NCCN clinical practice guidelines in oncology: kidney cancer. J Natl Compr Canc Netw 7: 618-630.
2. Aben KK, Heskamp S, Janssen-Heijnen ML, Koldewijn EL, van Herpen CM, Kiemeney LA, et al,. (2011) Better survival in patients with metastasized kidney cancer after nephrectomy: a population-based study in the Netherlands. Eur J Cancer 47: 2023-2032.
3. Culp SH, Tannir NM, Abel EJ, Margulis V, Tamboli P, Matin SF, et al,. (2010) Can we better select patients with metastatic renal cell carcinoma for cytoreductive nephrectomy? Cancer 116: 3378-3388.
4. Kavolius JP, Mastorakos DP, Pavlovich C, Russo P, Burt ME, Brady MS,. (1998) Resection of metastatic renal cell carcinoma. J Clin Oncol 16: 2261-2266.
5. Pfannschmidt J, Hoffmann H, Muley T, Krysa S, Trainer C, Dienemann H,. (2002) Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma. Ann Thorac Surg 74: 1653-1657.
6. Ruys AT, Tanis PJ, Iris ND, van Duijvendijk P, Verhoef C, Porte RJ, et al,. (2011) Surgical treatment of renal cell cancer liver metastases: a population-based study. Ann Surg Oncol 18: 1932-1938.
7. Aloia TA, Adam R, Azoulay D, Bismuth H, Castaing D,. (2006) Outcome following hepatic resection of metastatic renal tumours: the Paul Brousse Hospital experience. HPB 8: 100-105.
8. Adam R, Chiche L, Aloia T, Elias D, Salmon R, Rivoire M, et al,. (2006) Hepatic resection for non-colorectal non-endocrine liver metastases: analysis of 1452 patients and development of a prognostic model. Ann Surg 244: 524-535.
9. O'Rourke TR, Tekkis P, Yeung S, Fawcett J, Lynch S, Strong R, et al,. (2008) Longterm results of liver resection for non-colorectal, non-neuroendocrine metastases. Ann Surg Oncol 15: 207-218.
10. Karavias DD, Tepetes K, Karatzas T, Felekouras E, Androulakis J,. (2002) Liver resection for metastatic non-colorectal non-neuroendocrine hepatic neoplasms. Eur J Surg Oncol 28: 135-139.
11. Suppiah R, Shaheen PE, Elson P, Misbah SA, Wood L, Motzer RJ, et al,. (2006) Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma. Cancer 107: 1793-1800.
12. Thelen A, Jonas S, Benckert C, Lopez-Hanninen E, Rudolph B, Neumann U, et al,. (2007) Liver resection for metastases from renal cell carcinoma. World J Surg 31: 802-807.
13. Mayo SC, Gilson MM, Herman JM, Cameron JL, Nathan H, Edil BH, et al,. (2012) Management of patients with pancreatic adenocarcinoma: national trends in patient selection, operative management, and use of adjuvant therapy. J Am Coll Surg 214: 33-45.
14. Mayo SC, Heckman JE, Shore AD, Nathan H, Parikh AA, Bridges JF, et al,. (2011) Shifting trends in liver-directed management of patients with colorectal liver metastasis: a population-based analysis. Surgery 150: 204-216.
15. Asiyanbola B, Gleisner A, Herman JM, Choti MA, Wolfgang CL, Swartz M, et al,. (2009) Determining pattern of recurrence following pancreaticoduodenectomy and adjuvant 5-fluorouracil-based chemoradiation therapy: effect of number of metastatic lymph nodes and lymph node ratio. J Gastrointest Surg 13: 752-759.
16. Staehler MD, Kruse J, Haseke N, Stadler T, Roosen A, Karl A, et al,. (2010) Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis. World J Urol 28: 543-547.
17. Pulitano C, Bodingbauer M, Aldrighetti L, de Jong MC, Castillo F, Schulick RD, et al,. (2011) Liver resection for colorectal metastases in presence of extrahepatic disease: results from an international multi-institutional analysis. Ann Surg Oncol 18: 1380-1388.